Brian D W Chow1, Juliann L Reardon2, Emily O Perry3, Sonia S Laforce-Nesbitt4, Richard Tucker5, Joseph M Bliss6. 1. Marshfield Clinic Research Foundation, Marshfield, WI, USA. 2. Brown University, Providence, RI, USA. 3. Bristol County Agricultural High School, Dighton, MA, USA. 4. Brown University, Providence, RI, USA Women & Infants Hospital of Rhode Island, Providence, RI, USA. 5. Women & Infants Hospital of Rhode Island, Providence, RI, USA. 6. Brown University, Providence, RI, USA Women & Infants Hospital of Rhode Island, Providence, RI, USA jbliss@wihri.org.
Abstract
BACKGROUND: Colonization increases risk for invasive candidiasis in neonates. Breast milk host defense proteins may affect yeast colonization of infants. OBJECTIVE: This study aimed to evaluate breast milk host defense proteins relative to yeast colonization in infants. METHODS: Infants admitted for longer than 72 hours to the neonatal intensive care unit at Women & Infants Hospital in Providence, Rhode Island, were eligible. After consent, expressed breast milk and swabs from oral, rectal, and inguinal sites from infants were cultured weekly for 12 weeks, or until discharge, transfer, or death. Breast milk was tested for levels of human lactoferrin, lysozyme, apolipoprotein J, mucin-1, dermcidin, and soluble CD14 using commercial ELISA. Concentrations of these components were compared in breast milk received by infants who were colonized or not colonized with yeast. RESULTS: From an original cohort of 130, 61 infants had samples available for this subanalysis. A convenience sample of stored breast milk was analyzed. Median lactoferrin, apolipoprotein J, and mucin-1 did not differ between colonized and uncolonized groups. Soluble CD14 was higher in the surface-colonized group (1.8 μg/mL, n = 12) compared with the surface-uncolonized group (1.6 μg/mL, n = 12, P = .02). Median lysozyme levels were higher in the surface-uncolonized group (483.0 ng/mL, n = 12) versus the surface-colonized group (298.3 ng/mL, n = 12, P = .04). Median dermcidin levels were higher in the surface-uncolonized group (19.4 ng/mL, n = 12) versus the surface-colonized group (8.7 ng/mL, n = 12, P = .04). CONCLUSION: This study shows an association between colonization with Candida in neonates and lower levels of lysozyme and dermcidin in received breast milk. Further study is needed to confirm these findings.
BACKGROUND: Colonization increases risk for invasive candidiasis in neonates. Breast milk host defense proteins may affect yeast colonization of infants. OBJECTIVE: This study aimed to evaluate breast milk host defense proteins relative to yeast colonization in infants. METHODS:Infants admitted for longer than 72 hours to the neonatal intensive care unit at Women & Infants Hospital in Providence, Rhode Island, were eligible. After consent, expressed breast milk and swabs from oral, rectal, and inguinal sites from infants were cultured weekly for 12 weeks, or until discharge, transfer, or death. Breast milk was tested for levels of humanlactoferrin, lysozyme, apolipoprotein J, mucin-1, dermcidin, and soluble CD14 using commercial ELISA. Concentrations of these components were compared in breast milk received by infants who were colonized or not colonized with yeast. RESULTS: From an original cohort of 130, 61 infants had samples available for this subanalysis. A convenience sample of stored breast milk was analyzed. Median lactoferrin, apolipoprotein J, and mucin-1 did not differ between colonized and uncolonized groups. Soluble CD14 was higher in the surface-colonized group (1.8 μg/mL, n = 12) compared with the surface-uncolonized group (1.6 μg/mL, n = 12, P = .02). Median lysozyme levels were higher in the surface-uncolonized group (483.0 ng/mL, n = 12) versus the surface-colonized group (298.3 ng/mL, n = 12, P = .04). Median dermcidin levels were higher in the surface-uncolonized group (19.4 ng/mL, n = 12) versus the surface-colonized group (8.7 ng/mL, n = 12, P = .04). CONCLUSION: This study shows an association between colonization with Candida in neonates and lower levels of lysozyme and dermcidin in received breast milk. Further study is needed to confirm these findings.
Authors: B Schittek; R Hipfel; B Sauer; J Bauer; H Kalbacher; S Stevanovic; M Schirle; K Schroeder; N Blin; F Meier; G Rassner; C Garbe Journal: Nat Immunol Date: 2001-12 Impact factor: 25.606
Authors: B D W Chow; J R Reardon; E O Perry; S S Laforce-Nesbitt; R Tucker; J M Bliss Journal: J Pediatric Infect Dis Soc Date: 2014-01-15 Impact factor: 3.164
Authors: Joseph M Bliss; Kumar P Basavegowda; Wendy J Watson; Asad U Sheikh; Rita M Ryan Journal: Pediatr Infect Dis J Date: 2008-03 Impact factor: 2.129
Authors: Christian Hoffmann; Serena Dollive; Stephanie Grunberg; Jun Chen; Hongzhe Li; Gary D Wu; James D Lewis; Frederic D Bushman Journal: PLoS One Date: 2013-06-17 Impact factor: 3.240
Authors: Kasper Hettinga; Hein van Valenberg; Sacco de Vries; Sjef Boeren; Toon van Hooijdonk; Johan van Arendonk; Jacques Vervoort Journal: PLoS One Date: 2011-04-27 Impact factor: 3.240
Authors: M O Labéta; K Vidal; J E Nores; M Arias; N Vita; B P Morgan; J C Guillemot; D Loyaux; P Ferrara; D Schmid; M Affolter; L K Borysiewicz; A Donnet-Hughes; E J Schiffrin Journal: J Exp Med Date: 2000-05-15 Impact factor: 14.307
Authors: Fernanda Viviane Mariano; Camila Andrea Concha Gómez; Juliana de Souza do Nascimento; Harim Tavares Dos Santos; Erika Said Egal; Victor Angelo Martins Montalli; Pablo Agustin Vargas; Oslei Paes de Almeida; Albina Altemani Journal: Head Neck Pathol Date: 2016-05-13
Authors: Janine R Neumann; Suvarna Dash-Wagh; Alexander Jack; Andrea Räk; Kay Jüngling; Mohammad I K Hamad; Hans-Christian Pape; Michael R Kreutz; Martin Puskarjov; Petra Wahle Journal: PLoS One Date: 2019-02-13 Impact factor: 3.240